NV Bekaert SA (0OQJ)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 40.20 |
|---|---|
| 52-week range | 34.20 – 45.05 |
| Return, 1 month / 3 months | +5.4% / −2.9% |
| Return, 1 year / 3 years | +15.7% / +19.1% |
| Trend | Uptrend |
| RSI (14) | 55 |
| Volatility (1 year) | 26.4% |
| Worst drawdown (1 year) | -14.5% |
| Average daily value traded | 0.22M EUR |
| Dividend yield | 3.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
NV Bekaert SA is a Belgian manufacturer that turns steel into wire and wire products. It draws steel wire and makes steel cord used to reinforce tyres and other rubber goods, along with wire products for fencing, construction, agriculture and industrial uses. The company serves tyre makers, builders, manufacturers and other business customers from its base in Belgium, and it also supplies advanced materials and coating technologies to industrial markets around the world.
The shares are listed on the London Stock Exchange in UK under the code 0OQJ, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
NV Bekaert SA (0OQJ) trades on the London Stock Exchange in UK. It last closed at EUR 40.20 on 27 October 2026.
Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 1,691 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 15.7% and over the last three months it fell 2.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 51 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.7% | ||
| From 52-week high | -10.4% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -2.9% | ||
| 6-month return | -1.2% | ||
| 12-month return, skipping the last month | 9.8% | ||
| Stability (higher is calmer) | 80 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 26.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -14.5% | ||
| Liquidity | 38 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.22M EUR | ||
| Zero-volume days | 28.3% | ||
| Income | 49 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.4% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.5% |
|---|---|
| 1 month | +5.4% |
| 3 months | −2.9% |
| 6 months | −1.2% |
| 1 year | +15.7% |
| 3 years | +19.1% |
| 5 years | +22.6% |
Signals
| 50-day / 200-day average | 38.80 / 39.93 |
|---|---|
| Golden / death cross (60 days) | Death, 37 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.32 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 May 2026 | EUR 1.3650 |
| 16 May 2025 | EUR 1.3300 |
| 10 May 2024 | EUR 1.2600 |
| 11 May 2023 | EUR 1.1550 |
| 12 May 2022 | EUR 1.0500 |
| 14 May 2021 | EUR 0.7000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.